MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with E

Etravirine

Etravirine 100mg tablets

Incompatible

Stability notes for Etravirine 100mg tablets

Store in original bottle. Do not remove desiccant.

Provenance

This compatibility recommendation is derived from Intelence 100mg tablets (Janssen-Cilag Ltd).

Supplier

Intelence 100mg tablets (Janssen-Cilag Ltd)

Etravirine 200mg tablets

Incompatible

Stability notes for Etravirine 200mg tablets

Store in original bottle. Do not remove desiccant.

Provenance

This compatibility recommendation is derived from Intelence 200mg tablets (Janssen-Cilag Ltd).

Suppliers

Etravirine 200mg tablets (Unicorn Pharmaceuticals Ltd)
Intelence 200mg tablets (Janssen-Cilag Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.